| Ditemukan 1180 dokumen dengan kata kunci 4044 |
Simpan CSV  |
|
Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer
|
|
|
|
Prospective analysis of quality of life in elderly patients treated with adjuvant chemotherapy for non-small-cell lung cancer
|
|
|
|
Quality of life (QoL) analyses from OPTIMAL (CTONG-0802), a phase III, randomised, open-label study of first-line erlotinib versus chemotherapy in patients with advanced EGFR mutation-positive non-small-cell lung cancer (NSCLC)
|
|
|
|
Risk factors for local and regional recurrence in patients with resected N0–N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy
|
|
|
|
Impact of EGFR Inhibitor in Non–Small Cell Lung Cancer on Progression-Free and Overall Survival: A Meta-Analysis
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.9, 1 May, 2013: p.595-605 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Stage I–II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis
|
|
|
|
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
|
|
|
|
A SUMOylation-Dependent Pathway Regulates SIRT1 Transcription and Lung Cancer Metastasis
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.12, 19 June , 2013: p.887-898 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Investigation of Complement Activation Product C4d as a Diagnostic and Prognostic Biomarker for Lung Cancer
|
| No. Panggil: JNCI Journal of the National Cancer Institute; Volume 105, No.18, 18 September 2013: p.1385-1393 |
|
|
Koleksi: Artikel Internasional - Oxford ::
Cari yang mirip ::
Tambahkan ke Favorit ::
|
|
|
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer
|
|
|
Hasil Pencarian
